InfoBionic wants fees of $2.9m in ‘exceptional’ CardioNet suit

InfoBionic wants fees of $2.9m in ‘exceptional’ CardioNet suit

Alvotech, battling AbbVie over its Humira biosim, raises $450M and tees up Nasdaq debut

FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns

What the Moderna–NIH COVID vaccine patent fight means for research

Top headlines in Pharma and Biotech for the week of November 29th.